Faeth Therapeutics (FTH)

• Market cap: $860M
• 1 day: -7.74%
• 5 days: 36.83%
• 1 month: 140.87%
• 3 months: 10.65%
• 6 months: 183.67%
• Year to date: 245.7%
• 1 year: 312.36%
• 5 years: -78.51%
• 10 years: -91.17%
• Sector: Healthcare
• Industry: Biotechnology

About: Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.

Employees: 29